N
Nima Hemmat
Researcher at Tabriz University of Medical Sciences
Publications - 45
Citations - 901
Nima Hemmat is an academic researcher from Tabriz University of Medical Sciences. The author has contributed to research in topics: Cancer & Medicine. The author has an hindex of 10, co-authored 35 publications receiving 339 citations.
Papers
More filters
Journal ArticleDOI
The Regulatory Cross-Talk between microRNAs and Novel Members of the B7 Family in Human Diseases: A Scoping Review.
Noora Karim Ahangar,Noora Karim Ahangar,Nima Hemmat,Mohammad Khalaj-Kondori,Mahdi Abdoli Shadbad,Hani Sabaie,Ahad Mokhtarzadeh,Nazila Alizadeh,Afshin Derakhshani,Amir Baghbanzadeh,Katayoun Dolatkhah,Nicola Silvestris,Behzad Baradaran +12 more
TL;DR: In this paper, the authors conducted a scoping review to summarize and discuss the regulatory cross-talk between microRNAs and new B7 family immune checkpoint molecules, i.e., B7-H3, B7H4, B 7-H5, butyrophilin like 2 (BTNL2), B7 H3, H4, H5, H6, H7 H7, and ILDR2.
Journal ArticleDOI
Role of microRNAs in epidermal growth factor receptor signaling pathway in cervical cancer.
Nima Hemmat,Ahad Mokhtarzadeh,Mohammad Aghazadeh,Farhad Jadidi-Niaragh,Behzad Baradaran,Hossein Bannazadeh Baghi +5 more
TL;DR: Some predicted miRNAs were the candidate to target EGFR signaling pathway members differentially expressed in cervical cancer samples compared to normal samples and the role of their targets in the EGFR signaled pathway is highlighted.
Journal ArticleDOI
The role of antigen-presenting cells in the pathogenesis of COVID-19
Rana Farzi,Parisa Shiri Aghbash,Narges Eslami,Arezou Azadi,Ali Shamekh,Nima Hemmat,Taher Entezari-Maleki,Hossein Bannazadeh Baghi +7 more
TL;DR: In this article , the role of antigen-presenting cells (APCs) in the aforementioned immunological responses appears essential and detailed information about APCs' role in the infection and pathogenesis of SARS-CoV-2 and the effect of monoclonal antibodies in diagnosis and treatment is provided.
Journal ArticleDOI
Coronavirus Disease 2019: A Brief Review of the Clinical Manifestations and Pathogenesis to the Novel Management Approaches and Treatments.
Omid Kooshkaki,Afshin Derakhshani,Andelé M. Conradie,Nima Hemmat,Savio G. Barreto,Savio G. Barreto,Amir Baghbanzadeh,Pankaj Singh,Hossein Safarpour,Zahra Asadzadeh,Souzan Najafi,Oronzo Brunetti,Vito Racanelli,Nicola Silvestris,Behzad Baradaran +14 more
TL;DR: This review summarizes the current evidence regarding the epidemiology, pathogenesis, and management of patients with COVID-19 and aims to provide the reader with insights into CO VID-19 in pregnant patients and those with cancer, outlining necessary precautions relevant to cancer patients.
Journal ArticleDOI
Targeting TGF-β-Mediated SMAD Signaling Pathway via Novel Recombinant Cytotoxin II: A Potent Protein from Naja naja oxiana Venom in Melanoma.
Afshin Derakhshani,Nicola Silvestris,Nima Hemmat,Zahra Asadzadeh,Mahdi Abdoli Shadbad,Niloufar Sadat Nourbakhsh,Leila Mobasheri,Parviz Vahedi,Morteza Shahmirzaie,Oronzo Brunetti,Hossein Safarpour,Behzad Baradaran +11 more
TL;DR: Two regions of amino acids, 6–16 and 19–44, as predicted epitopes of this toxin, are essential for understanding the toxicity of rCTII and might serve as a potent and efficient anticancer drug in melanoma.